Concepedia

Shu Tamura

ST

Statistics

Publications

6

Citations

4.7K

H-Index

6

Active since

1995

Affiliations

Novartis (Switzerland)(Current)

Brigham and Women's Hospital

Hyogo Medical University

Harvard University

Oregon Health & Science University

Shu Tamura is an author at Novartis (Switzerland) specializing in molecular biology, oncology, and oncogenes.

Publications per year

1995–2000

6

Publications

6

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

Brian Druker, Shu Tamura, Elisabeth Buchdunger et al. · Nature Medicine · 1996 · 3.7K citations

, , +13

CGP 57148, a Tyrosine Kinase Inhibitor, Inhibits the Growth of Cells Expressing BCR-ABL, TEL-ABL, and TEL-PDGFR Fusion Proteins

Martin Carroll, Sayuri Ohno-Jones, Shu Tamura et al. · Blood · 1997 · 520 citations

, , +15

CGP 57148, a Tyrosine Kinase Inhibitor, Inhibits the Growth of Cells Expressing BCR-ABL, TEL-ABL, and TEL-PDGFR Fusion Proteins

Martin Carroll, Sayuri Ohno-Jones, Shu Tamura et al. · Blood · 1997 · 448 citations · Full text

, , +15

The SH2 domain of ABL is not required for factor-independent growth induced by BCR-ABL in a murine myeloid cell line.

Tsukasa Oda, Shu Tamura, Tetsuya Matsuguchi et al. · PubMed · 1995 · 43 citations

, , +8

Expression and role of p27kip1 in neuronal differentiation of embryonal carcinoma cells

Kobo Sasaki, Shu Tamura, Hisao Tachibana et al. · Molecular Brain Research · 2000 · 38 citations

, , +14

1–5 of 6